Markets › India › BOM › TITANBIO

Titan Biotech Limited

BOM:TITANBIOHealthcareBSE:COMDTY

₹408.45+0.38%At closeAt close · Tue 20 Oct · ≈ AED 15.78 · Market cap $176.88M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	47.1%	42.9%	40.5%	26.4%	53.6%	35.3%	—	—
Operating margin	31.2%	23.7%	36.0%	19.3%	13.6%	16.3%	16.3%	+0.0 pts
Net margin	21.3%	17.6%	17.3%	15.1%	13.8%	14.5%	14.5%	+0.0 pts
EBITDA margin	32.6%	25.9%	21.8%	21.8%	18.8%	18.7%	—	—
Return on equity	44.1%	25.1%	22.6%	18.6%	14.0%	16.5%	16.5%	+0.0 pts
Return on assets	30.1%	20.1%	18.5%	15.8%	12.3%	14.0%	14.0%	+0.0 pts
Return on capital employed	54.5%	32.1%	45.4%	22.8%	13.5%	17.9%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	14.7%	8.3%	6.3%	5.3%	1.6%	2.7%	—	—
Interest coverage	26.6×	33.5×	69.5×	27.0×	26.5×	36.9×	—	—
Current ratio	3.1×	3.8×	3.4×	3.8×	4.5×	3.3×	3.3×	+0.0%
Quick ratio	1.4×	1.7×	1.6×	1.3×	1.6×	1.1×	—	—
Cash ratio	0.3×	0.4×	0.2×	0.1×	0.3×	0.1×	0.1×	+0.0%
Asset turnover	1.4×	1.1×	1.1×	1.0×	0.9×	1.0×	—	—
Inventory turnover	2.3×	2.0×	2.4×	2.6×	1.4×	2.4×	—	—
Receivables turnover	7.9×	7.6×	30.6×	8.8×	8.3×	9.0×	—	—
Dividend payout	2.7%	5.7%	5.0%	6.0%	7.7%	5.5%	—	—